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Abstract
Objective: To estimate and compare the levels of serum copper and iron among subjects with oral submucous 
fibrosis (OSMF) of different clinical stages and healthy controls.
Study Design: Study sample comprised of 50 patients clinically diagnosed with OSMF and 50 healthy controls 
who were matched for age and gender. OSMF patients were categorised by clinical staging. Serum estimation of 
copper and iron was done using atomic absorbtion spectrophotometry. 
Results: Mean copper and iron level differed significantly (p<0.000) between the patients and controls with pa-
tients exhibiting higher copper (134.1±20.16) and lower iron (114.78±23.47) levels in contrast to controls who 
presented lower copper (114.8±12.36) and higher iron (130.86±31.01) levels in serum. There was a definite trend as 
(P<0.0001)  with cases having the lesion in faucial bands (1st stage) exhibiting the lowest serum copper and those 
in stage 3 (faucial, labial and buccal bands) presenting the highest copper levels in serum.
Conclusions: Copper level increased and iron level decreased in study group in comparison to healthy controls. 
Copper level increased as clinical stage of oral submucous fibrosis increased. 
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Introduction
Oral submucous fibrosis (OSMF) is a chronic disease of 
the oral cavity, which is characterized by an epithelial 
and subepithelial inflammatory reaction followed by fi-
broelastic changes in the submucosa. (1)
The disease is most commonly seen in people of south 
Asian countries or in south Asian immigrants to other 
parts of the world. (2) 
Clinically, patients suffer from gradual, progressive 
alterations in oral mucosa resulting in compromised 
mouth opening to various degrees. (3)
It is now evident that there exists a dose dependent rela-
tionship between oral submucous fibrosis and both fre-
quency and duration of chewing areca nut (4) which is a 
common habit in south and southeast Asia. (5)
Presently, it is a well recognized, potentially premalig-
nant condition with malignant potential and therefore a 
cause of concern for oral health care professionals. Ma-
lignant transformation rates as high as 7.6% have been 
reported from the Indian subcontinent over a 17 year 
period. (6) In the search for possible causes of malig-
nancies on the one hand, and the need for a modality 
affording early diagnosis and follow up on the other, at-
tention was paid to the role played by trace elements in 
malignancies. (7)
Among many trace elements, copper and iron are re-
quired for the functioning of numerous enzymes and 
therefore it is reasonable to assume that variation in se-
rum level of these biochemical markers may be associ-
ated with the pathogenesis of oral cancer and precancer-
ous states. (8) 
Iron has been recognized as an important element for 
maturation of epithelium and it is well documented that 
iron deficiency is associated with epithelial abnormali-
ties in addition to malignancies like post cricoid carci-
noma and tumours of the pharynx and mouth. (9)
Thus biochemical alterations of copper and iron con-
centrations in the serum of pre malignant patients can 
help not only in the early diagnosis, appropriate treat-
ment but also as an indicator for prognosis.
It has been postulated that altered serum copper and 
iron levels are observed among OSMF patients. Thus 
the present study aimed to estimate and compare the 
levels of serum copper and iron among subjects with 
oral submucuous fibrosis of different clinical stages and 
healthy controls.
Material and Methods 
Study sample comprised of 50 patients clinically diag-
nosed with OSMF and 50 healthy controls who were 
matched for age and gender. Patients attending the out-
patient department of Darshan Dental College and Hos-
pital, Udaipur were recruited in the study.
Ethical clearance was taken from the Ethical Commit-
tee, Darshan Dental College and Hospital and written 
informed consent was obtained from all the subjects.
Subjects suffering from chronic systemic illness and 
those consuming areca nut (in control group) were ex-
cluded. Inclusion criteria comprised subjects diagnosed 
with OSMF (in the study group) and subjects willing to 
provide written consent.  
The staging of the OSMF was done according to the 
criteria of clinical grading by Haider SM et al. Clinical 
staging was done depending on topography and extent 
of distribution of bands. Stage 1 subjects had faucial 
bands while those in stage 2 presented faucial and buc-
cal bands and among individuals in stage 3, faucial, 
buccal and labial bands were involved. (10)
Ten ml of blood was drawn intravenously and was 
centrifuged at 1000 – 1500 RPM for 15 minutes. Sub-
sequently, 5 ml of serum was collected which was 
analyzed for copper and iron with atomic absorbtion 
spectrophotometry in addition to haematological evalu-
ation. Haemoglobin was assessed by Sahli’s method and 
erythrocytic sedimentation rate (ESR) was calculated 
by Westergren’s method.
Data was entered in Microsoft Excel and analyzed us-
ing Statistical Package for Social Sciences (SPSS 15.0, 
Chicago., IL). Means and standard deviations were cal-
culated for serum copper and iron levels in study and 
control subjects.
Independent samples ‘t’ test was used to compare the 
mean values of serum iron and copper between the 
study subjects and control group while one way analy-
sis of variance (ANOVA) was used to assess the signifi-
cance in difference between the mean copper and iron 
levels based on the staging of OSMF. 
Step wise linear regression analysis was executed to as-
sess the influence of various independent variables (age, 
gender, hemoglobin, ESR, serum copper and iron lev-
els) on the dependent variable (study or control group)  
Results
In the present study, the youngest patient was 18 years 
of age while the oldest being 60 years. Among 50 pa-
tients in both the study and control groups, 45 (90%) 
were males and 5 (10%) were females. It is evident from 
(Table 1) that mean copper and iron level differed sig-
nificantly (p<0.05) between the patients and controls 
with patients exhibiting higher copper (134.1±20.16) and 
lower iron (114.78±23.47) levels in contrast to controls 
who presented lower copper (114.8±12.36) and higher 
iron (130.86±31.01) levels in serum.
One way ANOVA revealed a statistically significant 
difference in mean serum copper levels among patients 
in various clinical stages of OSMF. There was a definite 
trend as (P<0.0001) shown in (Table 2) with cases hav-
ing the lesion in faucial bands (1st stage) exhibiting the 
lowest serum copper and those in stage 3 (faucial, labial 
and buccal bands) presenting the highest copper levels 
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in serum. However, there was decrease in serum iron 
concentration as clinical stage increased but the differ-
ence observed was not statistically insignificant.
Step wise multiple linear regression analysis was exe-
cuted to assess the influence of age, gender, hemoglobin, 
ESR, serum copper and iron levels in predicting cases 
and controls. It is apparent from (Table 3) that serum 
copper and hemoglobin levels were the only significant 
variables. The first best predictor was serum copper 
level which exerted an influence of 25.3% whereas se-
rum copper and hemoglobin levels together exerted an 
influence of 41.9%.    
Discussion  
Among many trace elements associated with OSMF, 
role of copper and iron have been extensively studied 
and have been the subject of a multitude of investiga-
tions. 
In the present study, functional grading was not consid-
ered for staging of OSMF as it is based on the degree of 
mouth opening which is also dependent on many other 
factors like cheek flexibility, pain during opening, ul-
cers, vesicles, burning sensation and also psychological 
factors. 
It was observed that mean serum copper level was sig-
nificantly high in study group than in control group. In 
accordance with our findings, many past studies have 
observed raised copper level in the sera of patients with 
oral premalignant and malignant lesions. (8,11)
However, Trivedy et al. (12) observed that serum cop-
per remained normal in OSMF patients in contrast to 
the present study; this difference could be attributed to 
the small sample size and absence of a control group in 
their study. 
Though the definite reason for increase in serum cop-
per in premalignancies and malignancies is not known, 
it might be due to increased production of copper-con-
taining ceruloplasmin by liver as an inflammatory re-
sponse or due to decrease in catabolism of the serum 
ceruloplasmin. (13) 
It was noticed that all the subjects in the study group 
had the history of using areca nut and high levels of cop-
per in areca nut plays an initiating role in stimulation of 
fibrogenesis. (14)
Furthermore, a definite trend was observed with gradu-
al increase in serum copper level as the clinical stage of 
OSMF increased. Thus, there could be a direct relation 
between serum copper and extent of fibrosis.
Mean serum iron concentration in study subjects was 
lower than the control group. Anuradha and Devi have 
suggested that decreased iron levels in oral submucous 
fibrosis patients might be due to utilization of iron in 
collagen synthesis. (15)
Furthermore, lack of iron in the tissues results in de-
creased vascularity which facilitates percolation of 
 Group Mean Standard Deviation Significance
Copper  
Study 134.10 20.16 
0.005 
Control 114.84 12.36 
 Iron  
Study 114.78 23.47 
       0.019 
Control 130.86 31.01 
Table 1. Mean serum copper and iron concentrations (µg/100 ml) 
in study group and control group .
Independent samples‘t’ test. 
 Clinical 
staging n Mean 
Standard 
Deviation
Copper* 
Stage 1 10 110.37 14.22 
Stage 2 32 134.81 14.23 
Stage 3 8 160.95 7.66 
Total 50 134.10 20.16 
Iron
Stage 1 10 119.58 16.18 
Stage 2 32 115.40 24.66 
Stage 3 8 106.27 26.65 
Total 50 114.78 23.47 
Table 2. Copper and iron concentration (µg/100 ml) in serum of 
OSMF patients in relation to clinical staging. 
One way ANOVA. *p < 0.0001.
Model R RSquare
Adjusted
R Square 
Std. Error 
of Estimate 
1
2
0.503a
0.647b
0.253
0.419
0.245               0.437 
0.406               0.387 
Table 3. Step wise multiple linear regression analysis with 
age, gender, hemoglobin, ESR, serum Copper and Iron levels 
as independent variables and groups (patients and controls) as 
dependent variable. 
a Predictors: (Constant), Serum Copper level.    
b Predictors: (Constant), Serum Copper level, Haemoglobin 
level.
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arecoline. In vitro studies on human fibroblasts ob-
served that arecoline causes increased fibroblastic pro-
liferation and collagen formation which is a hallmark of 
OSMF. (4)
Nevertheless, the study is not free of limitations. The 
findings of the present study could not be generalized 
to all the OSMF patients because of the regional and 
cultural variation that occurs within and between the 
countries. 
The potential strong points of the study are that, equal 
number of cases and controls were included following 
stringent inclusion and exclusion criteria where subjects 
using areca nut were excluded from controls. Besides, 
Atomic Absorption spectro photometry was used to an-
alyze the elements which is more accurate in elemental 
analysis than traditional calorimetry method. Further-
more, in the present study the serum copper and iron 
levels were observed in relation to clinical staging. 
It can be concluded from the present study that serum 
copper and iron levels could be used as a potential prog-
nostic and diagnostic markers in OSMF patients. How-
ever, as there are controversial reports on the associa-
tion of OSMF and these trace elements future studies 
are anticipated on a larger heterogeneous population to 
confirm the hypothesis.
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